Hudson Technologies [HDSN] vs Chemours [CC] Detailed Stock Comparison

Hudson Technologies
NASDAQ
Loading...

Chemours
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Hudson Technologies wins in 12 metrics, Chemours wins in 5 metrics, with 0 ties. Hudson Technologies appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Hudson Technologies | Chemours | Better |
---|---|---|---|
P/E Ratio (TTM) | 24.83 | 67.83 | Hudson Technologies |
Price-to-Book Ratio | 1.70 | 7.58 | Hudson Technologies |
Debt-to-Equity Ratio | 2.34 | 1,818.41 | Hudson Technologies |
PEG Ratio | 22.57 | 5.19 | Chemours |
EV/EBITDA | 13.49 | 15.01 | Hudson Technologies |
Profit Margin (TTM) | 8.08% | -7.21% | Hudson Technologies |
Operating Margin (TTM) | 17.47% | -12.69% | Hudson Technologies |
EBITDA Margin (TTM) | 17.47% | N/A | N/A |
Return on Equity | 7.22% | -87.55% | Hudson Technologies |
Return on Assets (TTM) | 4.01% | 0.34% | Hudson Technologies |
Free Cash Flow (TTM) | $86.51M | $-993.00M | Hudson Technologies |
Dividend Yield | N/A | 6.82% | N/A |
1-Year Return | 24.59% | -32.78% | Hudson Technologies |
Price-to-Sales Ratio (TTM) | 1.93 | 0.31 | Chemours |
Enterprise Value | $355.29M | $5.64B | Chemours |
EV/Revenue Ratio | 1.58 | 0.96 | Chemours |
Gross Profit Margin (TTM) | 31.31% | 17.21% | Hudson Technologies |
Revenue per Share (TTM) | $5 | $39 | Chemours |
Earnings per Share (Diluted) | $0.40 | $-2.74 | Hudson Technologies |
Beta (Stock Volatility) | 0.96 | N/A | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Hudson Technologies vs Chemours Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Hudson Technologies | -0.87% | 4.15% | 18.55% | 45.75% | 76.22% | 71.88% |
Chemours | 0.08% | 1.67% | -1.93% | 11.74% | -33.30% | -27.11% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Hudson Technologies | 24.59% | -5.14% | 608.70% | 204.67% | 428.65% | 522.93% |
Chemours | -32.78% | -66.78% | -41.92% | 14.80% | -41.58% | -41.58% |
Performance & Financial Health Analysis: Hudson Technologies vs Chemours
Metric | HDSN | CC |
---|---|---|
Market Information | ||
Market Cap | $433.63M | $1.80B |
Market Cap Category | Small cap | Small cap |
10 Day Avg. Volume | 723,100 | 4,582,450 |
90 Day Avg. Volume | 450,743 | 4,943,027 |
Last Close | $9.69 | $12.19 |
52 Week Range | $5.11 - $10.06 | $9.13 - $22.38 |
% from 52W High | -3.63% | -45.53% |
All-Time High | $27.50 (Apr 10, 1995) | $58.08 (Oct 23, 2017) |
% from All-Time High | -64.76% | -79.01% |
Growth Metrics | ||
Quarterly Revenue Growth | -0.03% | 0.05% |
Quarterly Earnings Growth | 0.06% | 0.05% |
Financial Health | ||
Profit Margin (TTM) | 0.08% | -0.07% |
Operating Margin (TTM) | 0.17% | -0.13% |
Return on Equity (TTM) | 0.07% | -0.88% |
Debt to Equity (MRQ) | 2.34 | 1,818.41 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | $5.84 | $1.58 |
Cash per Share (MRQ) | $1.93 | $3.35 |
Operating Cash Flow (TTM) | $71.55M | $258.00M |
Levered Free Cash Flow (TTM) | $62.57M | $-17,500,000 |
Dividends | ||
Last 12-Month Dividend Yield | N/A | 6.82% |
Last 12-Month Dividend | N/A | $0.75 |
Valuation & Enterprise Metrics Analysis: Hudson Technologies vs Chemours
Metric | HDSN | CC |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 24.83 | 67.83 |
Forward P/E | 22.57 | 5.19 |
PEG Ratio | 22.57 | 5.19 |
Price to Sales (TTM) | 1.93 | 0.31 |
Price to Book (MRQ) | 1.70 | 7.58 |
Market Capitalization | ||
Market Capitalization | $433.63M | $1.80B |
Enterprise Value | $355.29M | $5.64B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 1.58 | 0.96 |
Enterprise to EBITDA | 13.49 | 15.01 |
Risk & Other Metrics | ||
Beta | 0.96 | N/A |
Book Value per Share (MRQ) | $5.84 | $1.58 |
Financial Statements Comparison: Hudson Technologies vs Chemours
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | HDSN | CC |
---|---|---|
Revenue/Sales | $55.34M | $1.37B |
Cost of Goods Sold | $43.28M | $1.13B |
Gross Profit | $12.07M | $236.00M |
Research & Development | N/A | $27.00M |
Operating Income (EBIT) | $3.08M | $78.00M |
EBITDA | $4.67M | $181.00M |
Pre-Tax Income | $3.65M | $0 |
Income Tax | $893,000 | $4.00M |
Net Income (Profit) | $2.76M | $-4.00M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | HDSN | CC |
---|---|---|
Cash & Equivalents | $81.05M | $464.00M |
Total Current Assets | $201.34M | $2.93B |
Total Current Liabilities | $52.39M | $1.67B |
Long-Term Debt | $4.42M | $4.28B |
Total Shareholders Equity | $246.82M | $580.00M |
Retained Earnings | $137.37M | $1.66B |
Property, Plant & Equipment | $52.25M | $8.30B |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | HDSN | CC |
---|---|---|
Operating Cash Flow | $13.98M | $-104.00M |
Capital Expenditures | $-1.41M | $-84.00M |
Free Cash Flow | $12.75M | $-196.00M |
Debt Repayment | N/A | $-46.00M |
Common Stock Repurchase | $-1.83M | N/A |
Short Interest & Institutional Ownership Analysis
Metric | HDSN | CC |
---|---|---|
Shares Short | 1.55M | 16.00M |
Short Ratio | 3.97 | 3.05 |
Short % of Float | 0.04% | 0.16% |
Average Daily Volume (10 Day) | 723,100 | 4,582,450 |
Average Daily Volume (90 Day) | 450,743 | 4,943,027 |
Shares Outstanding | 44.28M | 149.43M |
Float Shares | 35.57M | 139.95M |
% Held by Insiders | 0.12% | 0.00% |
% Held by Institutions | 0.83% | 0.99% |
Dividend Analysis & Yield Comparison: Hudson Technologies vs Chemours
Metric | HDSN | CC |
---|---|---|
Last 12-Month Dividend | N/A | $0.75 |
Last 12-Month Dividend Yield | N/A | 6.82% |
3-Year Avg Annual Dividend | N/A | $0.83 |
3-Year Avg Dividend Yield | N/A | 1.03% |
3-Year Total Dividends | N/A | $2.50 |
Ex-Dividend Date | N/A | Feb 28, 2025 |